News | News By Subject | News by Disease News By Date | Search News

Diabetes News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Johnson & Johnson (JNJ) Hands Over In-House Rival BetaLogics to ViaCyte, Gives Updates on Stem Cell Diabetes Trial     2/4/2016
Theracos Snags $25 Million for Diabetes Drug     1/18/2016
After Months of Rumors, MannKind Corporation (MNKD) and Sanofi (SNY) Terminate Afrezza Deal     1/5/2016
NovaTarg Therapeutics Aims to Reveal First Drug Candidates for Type 2 Diabetes, Kidney Disease in 2016     12/10/2015
Amidst Job Growth and Strong Stocks, Eli Lilly (LLY) Terminates BIL Diabetes Program     12/4/2015
Novo Nordisk A/S (NVO) Breathes New Life into XOMA  (XOMA) with $295 Million Diabetes Pact     12/2/2015
Derma Sciences (DSCI) Exploring Sale After Stopping Development of Its Only Drug     11/13/2015
Derma Sciences (DSCI)'s Phase III Aclerastide Study Terminated Due to Ineffectiveness     11/12/2015
Johnson & Johnson (JNJ) Unit, Hanmi Pharma Ink Diabetes and Obesity Pact Worth $915 Million     11/9/2015
In Attempt to Bolster Sagging Diabetes Revenue, Sanofi (SNY) Inks Deal with Hanmi Pharma Worth $4.2 Billion     11/6/2015
Another Deal for Sanofi (SNY) with $1.7 Billion Lexicon Pharma (LXRX) Diabetes Pact     11/6/2015
Arena (ARNA) to Chop 35% of U.S. Workforce and Push Clinical Programs Forward     10/29/2015
Macrocure (MCUR) Stock Plunges 63% as Lead Drug Fails Phase III Study     10/28/2015
Sanofi (SNY) Rumored to Be Freezing Hiring of Sales Staff for Inhaled Insulin Product Afrezza; MannKind Corporation (MNKD) Exec Denies It     10/26/2015
FDA Seeks More Data for AstraZeneca PLC (AZN)'s Diabetes Combo Treatment     10/16/2015

News from Around the Web
Surge In Obesity And Diabetes Could Be Linked To Food Additives, Georgia State University Study     2/10/2016
Molecular Link Between Psychiatric Disorders And Type 2 Diabetes Discovered, University of Massachusetts Medical School Scientists Reveal     2/8/2016
Way To Check Blood Glucose Using Far Infrared Light Discovered, Tohoku University Study     2/5/2016
Every Hour Spent On The Couch Ups Your Diabetes Risk By 22%, Maastricht University Research Shows     2/3/2016
Irregular Sleep Schedules Linked To Adverse Metabolic Health In Women, University of Pittsburgh Study     2/2/2016
Women With Sleeping Problems At Greater Diabetes Risk, Harvard School of Public Health Study     1/29/2016
Diabetes, Obesity In Mom Boost Autism Risk In Kids, Johns Hopkins University Study     1/29/2016
To Help Diabetics, Intelligent Socks Are Paired With Smartphones, Hebrew University of Jerusalem Study     1/28/2016
Early Puberty Linked To Gestational Diabetes, Clemson University Study     1/27/2016
No More Insulin Injections? MIT Study     1/26/2016
New Findings May Reveal Why Type 2 Diabetics Experience Smelling Problems, Karolinska Institute Study     1/21/2016
Weekend Catch-Up Sleep May Cut Diabetes Risk Tied To Sleep Loss, University of Chicago Study     1/19/2016
Potato-Rich Diet May Up Pregnancy Diabetes Risk, BMJ Publishes     1/13/2016
Studies Find Reducing Sugary Drinks Cuts Calories, But Only A Few     1/7/2016
Eating Potatoes On A Regular Basis May Up Risk Of T2DM, Osaka Center For Cancer And Cardiovascular Disease Prevention Study     12/31/2015

Press Releases
vTv Therapeutics Completes Enrollment Of Phase 2b Trial Evaluating TTP399 For The Treatment Of Type 2 Diabetes     2/10/2016
Tobira Therapeutics Inc. Completes Patient Recruitment For ORION Phase 2a Study Of Cenicriviroc In Obese Patients With Suspected Fatty Liver Disease     2/9/2016
Johnson & Johnson (JNJ) And Big Pharma Could Find A Diabetes "Cure" With PharmaCyte (PMCB) Biotech's Type 1 Diabetes Treatment     2/8/2016
Abbott (ABT) Scores CE Mark for Freestyle Libre Flash for Kids     2/5/2016
Medtronic (MDT)'s iPro2 Professional CGM Shows Benefits For People With Type 2 Diabetes     2/5/2016
Transition Therapeutics (TTH.TO) Announces Top Line Phase 2 Clinical Study Results Of Diabetes Drug Candidate TT401     2/1/2016
Adocia And Eli Lilly (LLY) Initiate Phase 1b Study Evaluating Ultra-Rapid Insulin BioChaperone Lispro U100 In Healthy Japanese Subjects     1/29/2016
Novo Nordisk A/S (NVO) Launches Tresiba (insulin Degludec Injection 200 Units/Ml) In The United States     1/26/2016
vTv Therapeutics Initiates Phase 2 Trial Evaluating TTP273 For The Treatment Of Type 2 Diabetes     1/21/2016
Kadimastem Receives Patent Allowance In The United States For Its Technology In The Field Of Diabetes Treatment     1/21/2016
Eli Lilly (LLY) Release: FDA Approves Humulin R U-500 Kwikpen     1/21/2016
ThromboGenics Ltd. (THR.BR) Enrolls First Patient In Phase II CIRCLE Trial Evaluating Multiple Doses Of Ocriplasmin To Induce A Total Posterior Vitreous Detachment In Patients With Non-Proliferative Diabetic Retinopathy (NPDR)     1/13/2016
Kowa Research Institute, Inc. Release: Landmark Trial Entitled "PROMINENT" To Explore The Prevention Of Heart Disease In Diabetic Patients With High Triglycerides And Low HDL-C     1/12/2016
Insulet (PODD) Enters Into Development Agreement With Eli Lilly (LLY) For OmniPod Delivery Of U200 Concentrated Insulin     1/12/2016
Eicosis, LLC Receives $4 Million To Develop Novel Treatment For Diabetic Neuropathic Pain     1/11/2016